Results 141 to 150 of about 23,130 (216)

A practical approach to normocalcemic primary hyperparathyroidism

Endocrine, 2021
Normocalcemic primary hyperparathyroidism is an entity on which several issues about its clinical management remains unclear. This is reflected in the main current guidelines, where there are no evidence-based specific recommendations. Through an exhaustive review of current literature, a clinical management algorithm for these patients is proposed. We
José Luis Muñoz de Nova   +3 more
openaire   +3 more sources

DXA-based bone strain index in normocalcemic primary hyperparathyroidism

Osteoporosis International, 2023
The trabecular and cortical bone assessed by bone strain index seems not to be significantly affected in NHPT.The natural history and bone involvement of normocalcemic hyperparathyroidism (NHPT) are not fully clarified yet. The bone strain index (BSI) is a deformation index based on the finite element method and can be applied to DXA scans.
Gaia Tabacco   +9 more
openaire   +3 more sources

Normocalcemic primary hyperparathyroidism: an update

Minerva Endocrinology, 2020
Normocalcemic primary hyperparathyroidism (NPHPT) is diagnosed in the setting of elevated PTH concentrations with consistently normal albumin-adjusted and ionized serum calcium levels, in absence of secondary causes for elevated PTH concentrations. In order to confirm persistence of the hyperparathyroid state, PTH levels should be elevated on at least ...
Antonio S, Salcuni   +6 more
openaire   +3 more sources

Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management

The American Journal of Surgery
Normocalcemic primary hyperparathyroidism (NPHPT), a variant of primary hyperparathyroidism (PHPT) characterized by persistently elevated parathyroid hormone (PTH) levels and normal serum calcium, has gained recognition as a substantial subset of PHPT cases. Despite its increasing prevalence, the precise pathophysiology and natural progression of NPHPT
Christopher Wu   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy